Sun Pharma - Business Outrank

Indian giant Sun Pharma is going to purchase US based immunotherapy and oncology company Checkpoint Therapeutics Inc. in Mar-24 for $355 million, which is its second big acquisition in three months. It enhances India’s biggest drug maker’s product portfolio in specialty therapies, especially in oncology. Checkpoint recently got the FDA approval for UNLOXCYT, a new treatment for metastatic cutaneous squamous cell carcinoma (cSCC), the second most common skin cancer in the US. The new therapy is expected to address a critical medical need with 1.8 million annual cases and 40,000 severe instances. “Patients with cSCC may soon have an important new treatment option” said Dilip Shanghvi, Sun Pharma’s chairman. “This acquisition enhances our onco derm portfolio and shows our dedication to innovation”. Checkpoint’s President and CEO, James Oliviero, also highlighted the global impact of the deal: “I believe this transaction will provide accelerated access to UNLOXCYT in the United States, Europe, and beyond.” Sun Pharma will buy the outstanding shares of Checkpoint at $4.10 per share, a 66% premium over its last closing price, and up to $0.70 per share more under certain circumstances. The deal is expected to be closed by June 2025. The US pharmaceutical market, the largest in the world, contributed one-third of Sun Pharma’s revenue in FY 2023–24. This acquisition also helps to cement Sun Pharma’s strategy to expand into the lucrative oncology segment.

What's Hot

Why ACL Reconstructions Fail: Dr Ashwani Maichand Elaborates on Key Causes of ACL Repair Failure and How to Avoid Them

A Bold New Shift in Customer Data Sharing

A Joyous Union Celebrated by the Upadhyay Family

Virus Susceptibility in Species: Study Reveals Surprising Findings

Effective Yoga Poses to Naturally Manage Blood Sugar Levels

Health Budgets Of States Fall Below 8%, Missing National Health Policy Targets

Priyanka Chopra’s Stunning Desi Look Steals the Spotlight at Her Brother’s Wedding Festivities

Jana Nayagan: Vijay Wields a Whip in Stunning 2nd Look Poster, Thrilling Fans

Assam’s Jatin Goswami Honored with Padma Bhushan for Sattriya Legacy

Vijay Vikram Singh Urgently Appeals for Respect Amidst Intense Backlash from Rajat Dalal Fans: ‘I Am Not Bigg Boss

Hindon: Incredible Air India Express Flights to Start from March 1 with Low Fares

Indian government approves Singapore Airlines bid to merge Vistara and Air India

Independence Day and Raksha Bandhan Fuel Airbnb Travel Rush

Virus Susceptibility in Species: Study Reveals Surprising Findings

Hindon: Incredible Air India Express Flights to Start from March 1 with Low Fares

Bachchan’s ₹83 Crore Duplex Sale Sparks Unbelievable Investment Growth

Kartik Aaryan’s Fitness Secret: How He Achieved a Stunning Transformation

Browsing: Sun Pharma

Sun Pharma Acquires US Oncology Firm for $355 Million Amid Cancer Drug Expansion

Why ACL Reconstructions Fail: Dr Ashwani Maichand Elaborates on Key Causes of ACL Repair Failure and How to Avoid Them

A Bold New Shift in Customer Data Sharing

A Joyous Union Celebrated by the Upadhyay Family

Burning Truths: Drax Under Fire for Using 250-Year-Old Trees in Biomass Operations

Our Picks

Why ACL Reconstructions Fail: Dr Ashwani Maichand Elaborates on Key Causes of ACL Repair Failure and How to Avoid Them

A Bold New Shift in Customer Data Sharing

A Joyous Union Celebrated by the Upadhyay Family

Most Popular

Why ACL Reconstructions Fail: Dr Ashwani Maichand Elaborates on Key Causes of ACL Repair Failure and How to Avoid Them

Top 10 World Best Business Opportunities In The World

Shaping The Future: Unmasking the energetic universe of innovative Startups

Subscribe to Updates

What's Hot

Browsing: Sun Pharma